Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

THE METABOLIC FATE OF CHLORTETRACYCLINE AND SOME COMPARISONS WITH OTHER TETRACYCLINES

H. J. Eisner and R. J. Wulf
Journal of Pharmacology and Experimental Therapeutics October 1963, 142 (1) 122-131;
H. J. Eisner
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. J. Wulf
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The metabolism of C14-labeled chlortetracycline following oral, intraperitoneal and intravenous administration in the rat and intravenous administration in the dog has been studied. In addition a comparison of the routes of excretion of total radioactivity from C14-chlortetracycline, C14-4-epichlortetracycline, H3-tetracycline and C14-demethylchlortetracycline after intravenous administration to these animals was undertaken.

The recovery of the administered radioactivity in the urine and feces of rats dosed orally or intravenously with C14-chlortetracycline varied from 76% to 97% of the dose after 48 to 72 hours. At this time only 33% to 70% of the administered microbiological activity was found. That portion of the dose excreted in the urine of dogs given this compound intravenously showed a similar relationship with the recovery of radioactivity being 48% while the microbiological recovery was 13%. The excreted C14, when examined by paper strip chromatography, was associated with two major components. These corresponded in Rf to unchanged chlortetracycline and to the microbiologically inactive 4-epichlortetracycline. Treatment of these components with acid or base yielded degradation products which were chromatographically similar to the respective anhydro or iso derivative. In the excreta of some of the animals, small amounts of a blue fluorescing material that corresponded to isochlortetracycline were observed.

Following intravenous administration of C14-labeled chlortetracycline, 4-epichlortetracycline or demethylchlortetracycline or H3-labeled tetracycline, significant amounts of radioactivity were excreted via the feces. Chlortetracycline and 4-epichlortetracycline were excreted to the greatest extent (40 to 50% of the dose) by this pathway followed in order by demethylchlortetracycline (15 to 30%) and tetracycline (9 to 20%).

Footnotes

    • Received April 5, 1963.
    • Accepted July 1, 1963.
  • The Williams & Wilkins Company

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 142, Issue 1
1 Oct 1963
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
THE METABOLIC FATE OF CHLORTETRACYCLINE AND SOME COMPARISONS WITH OTHER TETRACYCLINES
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

THE METABOLIC FATE OF CHLORTETRACYCLINE AND SOME COMPARISONS WITH OTHER TETRACYCLINES

H. J. Eisner and R. J. Wulf
Journal of Pharmacology and Experimental Therapeutics October 1, 1963, 142 (1) 122-131;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

THE METABOLIC FATE OF CHLORTETRACYCLINE AND SOME COMPARISONS WITH OTHER TETRACYCLINES

H. J. Eisner and R. J. Wulf
Journal of Pharmacology and Experimental Therapeutics October 1, 1963, 142 (1) 122-131;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Evidence That Melanocortin 4 Receptor Mediates Hemorrhagic Shock Reversal Caused by Melanocortin Peptides
  • Is Hydroxylamine-Induced Cytotoxicity a Valid Marker for Hypersensitivity Reactions to Sulfamethoxazole in Human Immunodeficiency Virus-Infected Individuals?
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics